APC selectively mediates response to chemotherapeutic agents in breast cancer

BACKGROUND: The Adenomatous Polyposis Coli (APC) tumor suppressor is mutated or hypermethylated in up to 70 % of sporadic breast cancers depending on subtype; however, the effects of APC mutation on tumorigenic properties remain unexplored. Using the Apc(Min/+) mouse crossed to the Polyoma middle T...

Descripción completa

Detalles Bibliográficos
Autores principales: VanKlompenberg, Monica K., Bedalov, Claire O., Soto, Katia Fernandez, Prosperi, Jenifer R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458029/
https://www.ncbi.nlm.nih.gov/pubmed/26049416
http://dx.doi.org/10.1186/s12885-015-1456-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458029/
https://www.ncbi.nlm.nih.gov/pubmed/26049416
http://dx.doi.org/10.1186/s12885-015-1456-x

Ejemplares similares